UnitedHealth Group has reached an agreement to acquire 80% stake in healthcare services provider American Health Network in order to expand its business.

Both companies involved in the transaction are based in the US.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The target company will become a part of the acquirer company’s OptumCare division, following the completion of the transaction.

Private equity (PE) firms Bain Capital Private Equity and Cinven Partners have reached an agreement over a takeover offer to acquire the entire outstanding shares of German-based pharmaceutical and healthcare company Stada Arzneimittel for approximately €4.1bn ($4.34bn).

“German healthcare company Fresenius SE & Co. has announced its plans to acquire Akorn, which has a current market value of approximately $3.7bn.”

The offer price represents an enterprise value of €5.3bn ($5.61bn).

The PE firms have agreed to pay €66 ($69.87) a share, which includes 2016 dividend of €0.72 ($0.76) a share proposed by Stada Arzneimittel’s management board, to the target company’s shareholders.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

German healthcare company Fresenius SE & Co. has announced its plans to acquire US-based pharmaceutical company Akorn, which has a current market value of approximately $3.7bn.

The acquisition is expected to complement the acquirer company’s Kabi medicines division.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact